- Home
- ADSE vs BVS Comparison
ADSE vs BVS Comparison
Compare ADSE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADSE | BVS |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | Ireland | United States |
| Employees | 302 | 940 |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 691.4M | 716.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ADSE | BVS |
|---|---|---|
| Price | $11.49 | $10.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 3.2K | ★ 426.4K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $549.86 | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $264.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.89 | $5.81 |
| 52 Week High | $13.90 | $11.25 |
Technical Indicators
Market Signals| Indicator | ADSE | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 50.13 | 61.00 |
| Support Level | $11.05 | $8.27 |
| Resistance Level | $12.24 | $11.00 |
| Average True Range (ATR) | 0.59 | 0.55 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 68.63 | 66.20 |
Price Performance
Historical ComparisonAbout ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.